ARTICLE | Company News

Biocontrol, Targeted Genetics deal

November 22, 2010 8:00 AM UTC

Targeted Genetics will acquire infectious disease company Biocontrol in a stock deal. Biocontrol shareholders will receive 22.6 million shares of Targeted Genetics' common stock, valued at $10.2 million based on Targeted Genetics' close of $0.45 on Nov. 11, before the deal was announced. Targeted Genetics will gain Biocontrol's bacteriophage technology. The combined company plans to develop therapies to treat antibiotic-resistant bacterial infections. ...